Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05107635 · ClinicalTrials.gov registry record
Inappropriate Sinus Tachycardia Registry
A clinical trial of Postural Tachycardia Syndrome and Inappropriate Sinus Tachycardia, sponsored by AtriCure.
- Recruiting
- Registry status
- 500
- Enrollment target
- 10
- Study locations
NCT05107635: Recruiting study of Postural Tachycardia Syndrome and Inappropriate Sinus Tachycardia, sponsored by AtriCure.
NCT05107635 is a study of Postural Tachycardia Syndrome and Inappropriate Sinus Tachycardia that is actively recruiting participants, run by AtriCure. The registered enrollment target is 500 participants, above the 56-participant average among 19 other Postural Tachycardia Syndrome trials with a reported enrollment target (793% higher). The trial reports 10 study locations across 8 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05107635, a study of Postural Tachycardia Syndrome and Inappropriate Sinus Tachycardia, is actively recruiting participants, sponsored by AtriCure.
- RECRUITING
- Registry status
- 500 participants
- Enrollment target
- 10
- Study locations
Study Summary
The primary objective of this registry is to capture real-world safety and performance data on AtriCure devices used to ablate cardiac tissue when treating Inappropriate Sinus Tachycardia (IST) or Postural Tachycardia Syndrome (POTS). This is a retrospective and prospective, multicenter, US/OUS, observational data registry.
Primary Outcome
The IST Registry will attempt to enroll all eligible patients at registry sites who have already had or are scheduled to have a procedure to treat IST/POTS that includes the use of at least one commercially available AtriCure cardiac ablation devices.
Conditions Studied
Interventions
- DEVICE AtriCure Commercially Available Devices
Study Locations (10)
California
- Stanford University - Palo Alto
- Sequoia Hospital - Redwood City
Florida
- University of Florida - Gainesville
- Sarasota Memorial Hospital - Sarasota
Kansas
- Kansas City Cardiac Arrhythmia Research - Kansas City
Maryland
- MedStar Health Research Institute - Hyattsville
Ohio
- The Carl & Edyth Lindner Center for Research & Education at The Christ Hospital - Cincinnati
Texas
- Texas Cardiac Arrhythmia Research Foundation - Austin
Utah
- Intermountain Medical Center - Murray
Other
- Universitair Ziekenhuis Brussels - Brussels
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 500 participants |
| Start Date | 2022-03-01 |
| Est. Completion | 2027-01 |
What NCT05107635 shows while recruiting
NCT05107635 is an observational study that tracks outcomes without assigning an intervention. The registered 500 participants enrollment target is mid-sized for trials with a published cap, above the 56-participant average among 19 other Postural Tachycardia Syndrome trials with a reported enrollment target (793% higher).
The record links to 2 conditions, with Postural Tachycardia Syndrome appearing as the primary indexed condition, and to 1 intervention - of which AtriCure Commercially Available Devices is the first listed.
NCT05107635 lists 10 locations in 8 states (California, Florida, Kansas).
Frequently Asked Questions
What is clinical trial NCT05107635 about?
NCT05107635 is a clinical study titled "Inappropriate Sinus Tachycardia Registry". The primary objective of this registry is to capture real-world safety and performance data on AtriCure devices used to ablate cardiac tissue when treating Inappropriate Sinus Tachycardia (IST) or Postural Tachycardia Syndrome (POTS). This is a retrospective and prospective, multicenter, US/OUS, obs...
What is the current status of trial NCT05107635?
This trial is currently recruiting. The enrollment target is 500 participants. The study started on 2022-03-01. Estimated completion is 2027-01.
What conditions does trial NCT05107635 study?
This clinical trial studies the following conditions: Postural Tachycardia Syndrome, Inappropriate Sinus Tachycardia.
What interventions are being tested in trial NCT05107635?
The interventions under investigation include: AtriCure Commercially Available Devices (DEVICE).
Who is sponsoring clinical trial NCT05107635?
This trial is sponsored by AtriCure, which has 23 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05107635 being conducted?
This trial has 10 study locations across California, Florida, Kansas, Maryland, Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Postural Tachycardia Syndrome
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05107635's enrollment target sits among peer trials
500 1st of 19 higher than 19 of 19 other Postural Tachycardia Syndrome trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Postural Tachycardia Syndrome trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Periaqueductal Gray-vagus Nerve Interface Malfunction Explain the Natural History With Its Numerous Co-morbidities?
RECRUITING · NA
-
Autoimmune Basis for Postural Tachycardia Syndrome
RECRUITING · NA
-
A Study of Pyridostigmine in Postural Tachycardia Syndrome
RECRUITING · Phase 2
-
Intravenous (IV) Saline and Exercise in Postural Tachycardia Syndrome (POTS)
ACTIVE NOT RECRUITING · NA
-
Acute Salt Handling in Orthostatic Intolerance
ACTIVE NOT RECRUITING · NA
-
POTS NET mRNA Functional Correlation With NET Activity
ACTIVE NOT RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00001230 · 500 participants
Host Response to Infection and Treatment in Filarial Diseases
- NCT00001529 · 500 participants
Improved Methods of Cell Selection for Bone Marrow Transplant Alternatives
- NCT00697411 · 500 participants
Study of Selected X-Linked Disorders: Aicardi Syndrome
- NCT00903110 · 500 participants
Global Patient Registry to Monitor Long-term Safety and Effectiveness of Increlex® in Children and Adolescents With Severe Primary Insulin-like Growth Factor-1 Deficiency (SPIGFD).
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI